Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Iterum Therapeutics Plc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Iterum Therapeutics Plc market cap is $53.00.
What is the 52-week high for Iterum Therapeutics Plc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Iterum Therapeutics Plc 52 week high is $0.798 as of October 10, 2026.